Desmopressin Acetate description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Desmopressin Acetate

Sun Pharmaceutical Industries Limited

Desmopressin Nasal Spray Solution, USP 0.01%


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

DESCRIPTION:





4664141222422
Desmopressin Acetate











CLINICAL PHARMACOLOGY:


  • The biphasic half-lives for intranasal desmopressin acetate were 7.8 and 75.5 minutes for the fast and slow phases, compared with 2.5 and 14.5 minutes for lysine vasopressin, another form of the hormone used in this condition. As a result, intranasal desmopressin acetate provides a prompt onset of antidiuretic action with a long duration after each administration.
  • The change in structure of arginine vasopressin to desmopressin acetate has resulted in a decreased vasopressor action and decreased actions on visceral smooth muscle relative to the enhanced antidiuretic activity, so that clinically effective antidiuretic doses are usually below threshold levels for effects on vascular or visceral smooth muscle.
  • Desmopressin acetate administered intranasally has an antidiuretic effect about one-tenth that of an equivalent dose administered by injection.
Human PharmacokineticsCONTRAINDICATIONS

INDICATIONS AND USAGE:


Central Cranial Diabetes Insipidus:







CONTRAINDICATIONS:






WARNINGS:

  • For intranasal use only.
  • Desmopressin nasal spray solution 0.01% should only be used in patients where orally administered formulations are not feasible.
  • Very rare cases of hyponatremia have been reported from world-wide postmarketing experience in patients treated with desmopressin acetate. Desmopressin acetate is a potent antidiuretic which, when administered, may lead to water intoxication and/or hyponatremia. Unless properly diagnosed and treated hyponatremia can be fatal. Therefore, fluid restriction is recommended and should be discussed with the patient and/or guardian. Careful medical supervision is required.
  • When desmopressin nasal spray solution 0.01% is administered, in particular in pediatric and geriatric patients, fluid intake should be adjusted downward in order to decrease the potential occurrence of water intoxication and hyponatremia (See PRECAUTIONS, Pediatric Use and Geriatric Use.) All patients receiving desmopressin nasal spray solution 0.01% therapy should be observed for the following signs or symptoms associated with hyponatremia: headache, nausea/vomiting, decreased serum sodium weight gain, restlessness, fatigue, lethargy, disorientation, depressed reflexes, loss of appetite, irritability, muscle weakness, muscle spasms or cramps and abnormal mental status such as hallucinations, decreased consciousness and confusion. Severe symptoms may include one or a combination of the following: seizure, coma and/or respiratory arrest. Particular attention should be paid to the possibility of the rare occurrence of an extreme decrease in plasma osmolality that may result in seizures which could lead to coma.
  • Desmopressin nasal spray solution 0.01% should be used with caution in patients with habitual or psychogenic polydipsia who may be more likely to drink excessive amounts of water, putting them at greater risk of hyponatremia.

PRECAUTIONS:

General:






Central Cranial Diabetes Insipidus:


Information for Patients:


Ensure that in children administration is under adult supervision in order to control the dose intake.

Laboratory Tests:


Drug Interactions:


Carcinogenesis, Mutagenesis, Impairment of Fertility:


Pregnancy:


Category B:2

Nursing Mothers:


Pediatric Use:


Central Cranial Diabetes Insipidus: WARNINGS

Geriatric Use:




CLINICAL PHARMACOLOGY, Human Pharmacokinetics CONTRAINDICATIONS

( WARNINGS).

ADVERSE REACTIONS:






    Desmopressin Acetate
  PLACEBO
(N=59)
20 mcg
(N=60)
40 mcg (N=61)
ADVERSE  REACTION
%
%
%
BODY AS A WHOLE
 
 
 
           Abdominal Pain
0
2
2
           Asthenia
0
0
2
           Chills
0
0
2
           Headache
0
2
5
NERVOUS SYSTEM
 
 
 
           Dizziness
0
0
3
RESPIRATORY SYSTEM
 
 
 
           Epistaxis
2
3
0
           Nostril Pain
0
2
0
           Rhinitis
2
8
3
DIGESTIVE SYSTEM 
 
 
 
           Gastrointestinal Disorder
0
2
0
           Nausea
0
0
2
SPECIAL SENSES
 
 
 
           Conjunctivitis
0
2
0
           Edema Eyes
0
2
0
           Lachrymation  Disorder
0
0
2

Post Marketing:




WARNINGS

OVERDOSAGE:


WARNINGS

50

DOSAGE AND ADMINISTRATION:

Central Cranial Diabetes Insipidus:


WARNINGS PRECAUTIONS, Pediatric Use Geriatric Use



Geriatric Use:


CLINICAL PHARMACOLOGY, Human Pharmacokinetics CONTRAINDICATIONS, PRECAUTIONS, Geriatric Use

HOW SUPPLIED:


Storage:








Keep out of reach of children



Caraco Pharmaceutical Laboratories, Ltd.



Sun Pharmaceutical Industries Ltd.




PATIENT INSTRUCTION GUIDE


Desmopressin Nasal Spray Solution, USP 0.01%

A better way to deliver desmopressin nasal spray solution, USP 0.01%

Delivering desmopressin nasal spray solution, USP 0.01% more efficiently



CAUTION:

Ensure that in children administration is under adult supervision in order to control the dose intake.



Using your Desmopressin Nasal Spray Solution 0.01% Pump
Desmopressin Acetate

1. Remove protective cap.

2. The spray pump must be primed prior to the first use. To prime pump, press down five (5) times.

3. Once primed, the spray pump delivers 10 micrograms of medication each time it is pressed. To ensure dosing accuracy, hold bottle upright.

To administer a 10 micrograms dose, place the spray nozzle in nostril and press the spray pump once. If a higher dose has been prescribed, spray half the dose in each nostril. The spray pump cannot be used for doses less than 10 micrograms or doses other than multiples of 10 micrograms.

4. Replace the protective cap on bottle after use, and store in refrigerator. The pump will stay primed for up to one week under refrigeration. If the product has not been used for a period of one week, re-prime the pump by pressing once.



Desmopressin Acetate
Storage:




Caraco Pharmaceutical Laboratories, Ltd.



Sun Pharmaceutical Industries Ltd.




PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - LABEL


NDC 62756-161-91
Desmopressin Nasal Spray Solution, USP 0.01%
0.1 mg/mL
5 mL
REFRIGERATE
Rx only
FOR INTRANASAL USE ONLY.
50 doses of 10 mcg
Desmopressin Acetate

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - CARTON


NDC 62756-161-91
Desmopressin Nasal Spray Solution, USP 0.01%
0.1 mg/mL
(0.01 mg/Spray)
FOR INTRANASAL USE ONLY.
Rx only
5 mL
50 doses of 10 mcg
SUN PHARMA
Desmopressin Acetate

Desmopressin Acetate

Desmopressin Acetate SOLUTION

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:62756-161
Route of Administration NASAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
desmopressin acetate DESMOPRESSIN 0.1 mg

Inactive Ingredients

Ingredient Name Strength
CHLOROBUTANOL HEMIHYDRATE
SODIUM CHLORIDE
HYDROCHLORIC ACID
water

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 5 in 1 BOTTLE, PUMP
2 NDC:62756-161-91 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077212 2012-04-14


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.